Back to search

Article

Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction

2024-11-21

Abstract excerpt

<h4>Background: </h4> Hyperkalemia is a common electrolyte disorder in patients with heart failure and reduced ejection fraction (HFrEF). Renin-angiotensin-aldosterone system inhibitors (RAASi) have been shown to improve survival and decrease hospitalization rates, although they may increase the serum potassium levels. Hyperkalemia has significant clinical and economic implications, and is associated with increase...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ae94823-8e96-5206-aefe-d191acfa5611
DOI
10.20944/preprints202411.1586.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection FractionDOI 10.20944/preprints202411.1586.v1
Observed Frequency and Clinical Management of Sodium Polystyrene Sul-fonate Treated Hyperkalemia in Patients with Chronic Heart Failure in a Private Center in Costa RicaSemantic proximity
Incidence, risk factors, and prognosis of hypokalemia in patients with normokalemia at hospital admission.Semantic proximity
Clinical phenotypes according to diuretic combination in acute heart failure.Semantic proximity
Prevalence of hypokalemia and its correlation with hematological parameters and biomarkers of inflammation in adult COVID-19 patients in southeastern Iran, 2021-2022: a cross-sectional studySemantic proximity
Economic and clinical burden in patients with primary hyperoxaluria treated with dialysis: A real- world evidence study in the United StatesSemantic proximity
Quality of life in hyperkalemia: baseline analysis of a cohort study of management of hyperkalemia in patients with chronic kidney disease or heart failure in JapanSemantic proximity
Clinical Profile, Aetiology, and Temporal Trends of Hospitalized Heart Failure Patients in a Private Tertiary Hospital in Sierra Leone (2021 – 2025)Semantic proximity
Analysing the impact of a guideline for the use of new potassium binders for treatment of chronic hyperkalaemia to maximise inhibition of renin–angiotensin–aldosterone system (RAAS) within the general nephrology clinic?Semantic proximity
The clinical effectiveness of tolvaptan in critically ill patients with or without heart disease: A retrospective observational studySemantic proximity
Low T3 syndrome in heart failure: prevalence and its relationship with disease severity and ejection fraction.Semantic proximity
Cardiorenal and Metabolic Convergence in Acute Heart Failure: Severe Cardiorenometabolic Syndrome as a High-Risk PhenotypeSemantic proximity
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.Semantic proximity
Select a neighboring publication to make it the new centre.